Latest News
White House Announces BRAIN Initiative
The BRAIN Initiative Challenges Researchers to Unlock Mysteries of Human Mind.
Improving The Lives Of Those Affected By Brain Tumors
Ashley Varner guest blogs about her social work pilot study on the lived experience of family members who live with someone diagnosed with a primary malignant brain tumor.
Low Grade Glioma Research Workshop
In partnership with UCSF and MD Anderson, ABC2 brought together researchers from leading medical centers and biotech companies to strategize new therapeutic paths to treat Low Grade Gliomas.
ABC2-Funded Research Featured in Scientific American
The collaboration between academic and industry researchers aims to develop a test to detect genetic brain tumor mutations in cerebral spinal fluid and blood.
Into Fearless, Uncharted Territory: The Brain Cancer Expedition
Max Wallace, CEO of Accelerate Brain Cancer Cure, guest blogs for The Case Foundation about our new project that could revolutionize treatment for patients.
Josh Sommer Named To Forbes' "30 Under 30" List
Josh Sommer is the founder of the Chordoma Foundation. He is a good friend and we work closely with his organization on a variety of rare disease initiatives.
A Tribute to Anne Feeley
Anne will always be remembered for her kind smile, wonderful sense of humor and determination to make this world a better place.
Max Wallace To Speak At Dupont Summit
Max will join a panel of R&D experts to discuss "The Evolving Research Enterprise: The Role of Foundations and Strategic Funding."
Avastin Update - November, 2012
Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.
ABC2 Science Salons
A Unique Opportunity To Learn About The Most Innovative New Trends In Brain Tumor Research.
2012 Annual Scientific Gathering
A blog post from Max Wallace, CEO of Accelerate Brain Cancer Cure.
ABC2 Is A "Power Player" Says Xconomy
Max Wallace, CEO of Accelerate Brain Cancer Cure, is featured this week in the leading innovation economy publication, Xconomy.
U.Va. Cancer Initiative Invests $300,000 in Public-Private Research Partnerships
The projects were selected by a review committee, which includes Max Wallace, CEO of Accelerate Brain Cancer Cure.
ABC2 Fellows Program
We are pleased to launch our Fellows program for young scientific investigators. They will examine business development and strategy issues within pharmaceutical, biotechnology, financial and philanthropic organizations.
Avastin Update
Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin study by Genentech.
Study suggests new treatment target for deadly brain tumors
Scientists led by Dr. Luis Parada at UT Southwestern Medical Center have identified a cancer stem cell-like treatment target against glioblastoma (GBM) - the most deadly type of brain tumor.
Research May Lead to New Treatment for Glioblastoma Brain Tumor
The study, led by Antonio Iavarone at Columbia University Medical Center, pinpoints a genetic cause of some cases of glioblastoma (GBM) -- the most lethal form of brain tumor.
Vanderbilt-led team to develop 'microbrain' to improve drug testing
The research is part of the National Institute of Health's $70 million "Tissue Chip For Drug Testing" program.
Subtype of Glioblastoma Multiforme (GBM) Is Associated With Longer Life Expectancy
University of Wisconsin-Madison research shows new prognosis tool for deadly brain cancer.
Researchers Determine Pathway for Origin of Most Common Form of Brain and Spinal Cord Tumor
Johns Hopkins scientists hope discovery will drive drug treatments for meningioma brain tumors
Canadian "Dream Team" To Tackle Deadly Brain Cancer
A multi-partner, $8.2 million investment will develop new glioblastoma treatments.
NIH study finds childhood CT scans linked to leukemia and brain cancer later in life
Overall risk is low and outweighed by the reason the child needs the CT scan in the first place.
Wisconsin Team Reveals Way to Treat Drug-resistant Brain Tumor Cells
New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to current chemotherapies.
Race for Hope DC: "Where I Needed to Be..."
Brain tumor survivor Mark Green participated in the 15th Annual Race for Hope DC and shares his story.
